Skip to content

Clinical trials

Phase 3 Psoriasis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psoriasis Phase: Phase 3 Country / region: Australia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20105
20112
20125
20132
20144
20161
20175
20188
20191
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated5
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC6
Amgen5
Eli Lilly and Company5
UCB Biopharma SRL5
AbbVie3
Bristol-Myers Squibb3
Novartis Pharmaceuticals3
Pfizer3
Bausch Health Americas, Inc.2
Vanda Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psoriasis38
Arthritis, Psoriatic10
Arthritis6
Inflammation3
Skin Diseases3
Bronchiolitis Obliterans Syndrome2
Dermatitis2
Joint Diseases2
Lymphoma, Follicular2
Musculoskeletal Diseases2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.